Pre-Dialysis Systolic Blood Pressure-Variability Is Independently Associated with All-Cause Mortality in Incident Haemodialysis Patients

被引:31
|
作者
Selvarajah, Viknesh [1 ,2 ]
Pasea, Laura [3 ]
Ojha, Sanjay [2 ]
Wilkinson, Ian B. [4 ]
Tomlinson, Laurie A. [4 ]
机构
[1] Univ Cambridge, Dept Med, Clin Pharmacol Unit, Cambridge CB2 2QQ, England
[2] Cambridge Univ Hosp NHS Fdn Trust, Dept Nephrol, Cambridge, England
[3] Univ Cambridge, Ctr Appl Med Stat, Dept Publ Hlth & Primary Care, Inst Publ Hlth, Cambridge CB2 2QQ, England
[4] Univ Cambridge, Cambridge Clin Trials Unit, Cambridge CB2 2QQ, England
来源
PLOS ONE | 2014年 / 9卷 / 01期
关键词
CARDIOVASCULAR RISK; DISEASE PATIENTS;
D O I
10.1371/journal.pone.0086514
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Systolic blood pressure variability is an independent risk factor for mortality and cardiovascular events. Standard measures of blood pressure predict outcome poorly in haemodialysis patients. We investigated whether systolic blood pressure variability was associated with mortality in incident haemodialysis patients. We performed a longitudinal observational study of patients commencing haemodialysis between 2005 and 2011 in East Anglia, UK, excluding patients with cardiovascular events within 6 months of starting haemodialysis. The main exposure was variability independent of the mean (VIM) of systolic blood pressure from short-gap, pre-dialysis blood pressure readings between 3 and 6 months after commencing haemodialysis, and the outcome was all-cause mortality. Of 203 patients, 37 (18.2%) patients died during a mean follow-up of 2.0 (SD 1.3) years. The age and sex-adjusted hazard ratio (HR) for mortality was 1.09 (95% confidence interval (CI) 1.02-1.17) for a one-unit increase of VIM. This was not altered by adjustment for diabetes, prior cardiovascular disease and mean systolic blood pressure (HR 1.09, 95% CI 1.02-1.16). Patients with VIM of systolic blood pressure above the median were 2.4 (95% CI 1.17-4.74) times more likely to die during follow-up than those below the median. Results were similar for all measures of blood pressure variability and further adjustment for type of dialysis access, use of antihypertensives and absolute or variability of fluid intake did not alter these findings. Diastolic blood pressure variability showed no association with all cause mortality. Our study shows that variability of systolic blood pressure is a strong and independent predictor of all-cause mortality in incident haemodialysis patients. Further research is needed to understand the mechanism as this may form a therapeutic target or focus for management.
引用
收藏
页数:6
相关论文
共 50 条
  • [31] Hypothyroidism is associated with all-cause mortality in a national cohort of chronic haemodialysis patients
    Lin, Hsuan-Jen
    Lin, Chung-Chih
    Lin, Hsuan Ming
    Chen, Hsuan-Ju
    Lin, Che-Chen
    Chang, Chiz-Tzung
    Chou, Che-Yi
    Huang, Chiu-Ching
    NEPHROLOGY, 2018, 23 (06) : 559 - 564
  • [32] ABNORMAL GLOBAL LONGITUDINAL STRAIN IS ASSOCIATED WITH ALL-CAUSE MORTALITY IN HAEMODIALYSIS PATIENTS
    Chiu, Diana
    Green, Darren
    Kalra, Philip
    Abidin, Nik
    HEART, 2016, 102 : A90 - A91
  • [33] Statin initiation and all-cause mortality in incident statin-naive dialysis patients
    Kim, Ji Eun
    Park, Sehoon
    Kim, Myeong-Seok
    Kang, Sung Jin
    Lee, Jang Wook
    Kim, Kwang Soo
    Kim, Yong Chul
    Kim, Dong Ki
    Joo, Kwon Wook
    Kim, Yon Su
    Park, Minsu
    Lee, Hajeong
    ATHEROSCLEROSIS, 2021, 337 : 59 - 65
  • [34] Atherogenic index predicts all-cause and cardiovascular mortality in incident peritoneal dialysis patients
    Deng, Jihong
    Tang, Xingming
    Tang, Ruiying
    Chen, Jiexin
    Guo, Huankai
    Zhou, Qian
    Zhan, Xiaojiang
    Long, Haibo
    Peng, Fenfen
    Wang, Xiaoyang
    Wen, Yueqiang
    Feng, Xiaoran
    Su, Ning
    Tian, Na
    Wu, Xianfeng
    Xu, Qingdong
    ATHEROSCLEROSIS, 2023, 387
  • [35] Relationship between History of Ischemic Stroke and All-Cause Mortality in Incident Dialysis Patients
    Kojima, Masayasu
    Inaguma, Daijo
    Koide, Shigehisa
    Koshi-Ito, Eri
    Takahashi, Kazuo
    Hayashi, Hiroki
    Tsuboi, Naotake
    Hasegawa, Midori
    Yuzawa, Yukio
    NEPHRON, 2019, 143 (01) : 43 - 53
  • [36] High Variability of Serum Albumin Is Associated with Increased Risk of All-Cause Mortality in Patients on Peritoneal Dialysis
    Afghahi, Hanri
    Nasic, Salmir
    Peters, Bjorn
    Warme, Anna
    Rydell, Helena
    Svensson, Maria K.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [37] Pre-Dialysis Transition High vs Moderate Dose Statin Use and Post-Dialysis Transition All-Cause Mortality
    Streja, Elani
    Soohoo, Melissa
    Moradi, Hamid
    Kashyap, Moti L.
    Molnar, Miklos Z.
    Gillen, Daniel L.
    Kovesdy, Csaba P.
    Kalantar-Zadeh, Kamyar
    CIRCULATION, 2017, 136
  • [38] Visit-to-visit systolic blood pressure variability predicts all-cause and cardiovascular mortality after lacunar infarct
    Lau, K. K.
    Wong, Y. K.
    Chang, R. S. K.
    Teo, K. C.
    Hon, S. F. K.
    Chan, K. H.
    Wat, K. L.
    Cheung, R. T. F.
    Li, L. S. W.
    Siu, C. W.
    Ho, S. L.
    Tse, H. F.
    EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 (02) : 319 - 325
  • [39] Mitral annulus calcification is independently associated with all-cause mortality
    Ramaraj, Radhakrishnan
    Manrique, Coraly
    Hashemzadeh, Mehrnoosh
    Movahed, Mohammad Reza
    EXPERIMENTAL & CLINICAL CARDIOLOGY, 2013, 18 (01) : E5 - E7
  • [40] Left ventricular hypertrophy is independently associated with all-cause mortality
    Movahed, Mohammad Reza
    Ramaraj, Radhakrishnan
    Manrique, Coraly
    Hashemzadeh, Mehrnoosh
    AMERICAN JOURNAL OF CARDIOVASCULAR DISEASE, 2022, 12 (01): : 38 - 41